These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6896580)

  • 1. Pharmacodynamic evaluation of selective antimuscarinic properties of pirenzepine in the rat.
    Del Soldato P; Pagani F
    Pharmacol Res Commun; 1982 Mar; 14(3):279-87. PubMed ID: 6896580
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of selectivity of two different antimuscarinic substances.
    Engelhorn R
    Scand J Gastroenterol Suppl; 1982; 72():49-58. PubMed ID: 6957997
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the effects of some antimuscarinic agents on gastric damage and pupillary reflex in the rat.
    Daniotti S; Del Soldato P
    Br J Pharmacol; 1984 Jun; 82(2):305-7. PubMed ID: 6547361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.
    Jaup BH; Stockbrügger RW; Dotevall G
    Scand J Gastroenterol Suppl; 1980; 66():89-94. PubMed ID: 6941380
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats.
    Pendleton RG; Williams M; Chung C; Cook P; Risley E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):210-4. PubMed ID: 6547998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cytoprotection by pirenzepine is not mediated by catecholamines.
    Martinotti E; Bernardini C; Del Tacca M; Pellegrini M; Soldani G; Bertelli A
    Acta Physiol Hung; 1984; 64(3-4):219-24. PubMed ID: 6549422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of "selective" antimuscarinic agents on gastric acid secretion and motility.
    Subissi A; Guelfi M; Maggi CA; Meli A
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):313-9. PubMed ID: 3161479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
    Galmiche JP; Lerebours E; Colin R
    Med Chir Dig; 1980; 9(4):331-4. PubMed ID: 6894012
    [No Abstract]   [Full Text] [Related]  

  • 9. Pirenzepine selectively inhibits gastric acid secretion: a comparative pharmacological study between pirenzepine and seven other antiacetylcholine drugs.
    Heathcote BV; Parry M
    Scand J Gastroenterol Suppl; 1980; 66():15-26. PubMed ID: 6113681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents.
    Takeda F; Kitagawa H; Kohei H
    Jpn J Pharmacol; 1985 Aug; 38(4):337-46. PubMed ID: 3865005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
    Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
    Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
    Konturek SJ; Obtulowicz W; Kwiecień N; Dobrzańska M; Swierczek J; Kopp B; Olesky J
    Scand J Gastroenterol Suppl; 1980; 66():63-9. PubMed ID: 6941379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of pirenzepine and atropine on gastric acid secretion, salivary secretion and pupil diameter in the rat.
    Parry M; Heathcote BV
    Life Sci; 1982 Oct; 31(14):1465-71. PubMed ID: 6897277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
    Matsuo Y; Seki A
    Arzneimittelforschung; 1979; 29(7):1028-35. PubMed ID: 582994
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)].
    von Kleist D; Staud R; Stopik D; Hampel HE
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):110-4. PubMed ID: 6893819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats.
    Scarpignato C; Girone MG; Tirelli F; Bertaccini G
    Eur J Pharmacol; 1984 Jun; 101(3-4):193-200. PubMed ID: 6547908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers.
    Jaup BH; Dotevall G
    Scand J Gastroenterol; 1981; 16(6):769-73. PubMed ID: 6119766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
    Okabe S; Tabata K; Kawakami M
    Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA; Brogden RN
    Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirenzepine: a selective anticholinergic for peptic ulcer.
    Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.